Human Bone Marrow Mesenchymal Stem Cells Display Anti-Cancer Activity in SCID Mice Bearing Disseminated Non-Hodgkin's Lymphoma Xenografts

BACKGROUND: Although multimodality treatment can induce high rate of remission in many subtypes of non-Hodgkin's lymphoma (NHL), significant proportions of patients relapse with incurable disease. The effect of human bone marrow (BM) mesenchymal stem cells (MSC) on tumor cell growth is controve...

Descripción completa

Detalles Bibliográficos
Autores principales: Secchiero, Paola, Zorzet, Sonia, Tripodo, Claudio, Corallini, Federica, Melloni, Elisabetta, Caruso, Lorenzo, Bosco, Raffaella, Ingrao, Sabrina, Zavan, Barbara, Zauli, Giorgio
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886845/
https://www.ncbi.nlm.nih.gov/pubmed/20585401
http://dx.doi.org/10.1371/journal.pone.0011140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886845/
https://www.ncbi.nlm.nih.gov/pubmed/20585401
http://dx.doi.org/10.1371/journal.pone.0011140

Ejemplares similares